ArticlePharmacoEconomics2014

Authors' reply to Gandjour: "Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines".

A T Newall et al.PubMed ↗Publisher ↗

No numbers read from the abstract.